| Sarah D Infantino, SLP | |
|
314 S Manning Blvd, Albany, NY 12208-1708 | |
| (518) 437-5900 | |
| Not Available |
| Full Name | Sarah D Infantino |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 314 S Manning Blvd, Albany, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598812281 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1392 (Nebraska) | Secondary |
| 235Z00000X | Speech-language Pathologist | 016576 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah D Infantino, SLP 314 S Manning Blvd, Albany, NY 12208-1708 Ph: (518) 437-5528 | Sarah D Infantino, SLP 314 S Manning Blvd, Albany, NY 12208-1708 Ph: (518) 437-5900 |
News Archive
Quintiles today announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany. Under the alliance, Quintiles will execute a comprehensive commercial sales effort for the product launch and provide additional services in consulting, market access, market intelligence and analytics, regulatory and post-marketing pharmacovigilance.
In contrast to intramuscular vaccines, only nasal vaccines are able to block the virus in the nose by inducing local immunity in the nasal mucosa, i.e. the portal of entry and multiplication of the virus.
Genentech, a member of the Roche Group, today announced that BRIM3, a Phase III clinical study of RG7204, met its co-primary endpoints showing a significant survival benefit in people with previously untreated BRAF V600 mutation-positive metastatic melanoma.
Despite strong evidence of its effectiveness, few of the young women who are eligible for the human papillomavirus (HPV) vaccine take it, according to research presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held Nov. 7-10.
NanoPass Technologies Ltd., a pioneer in intradermal delivery solutions for vaccines, announced today that it has entered into a license agreement for the supply of MicronJet600, its microneedle delivery device, to Circassia Pharmaceuticals plc. (Oxford, UK), a specialty biopharmaceutical company focused on the allergy market.
› Verified 1 days ago
Natalia M Martinez, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Rapp Rd, Albany, NY 12203 Phone: 518-867-3061 Fax: 518-867-3066 | |
Mrs. Amy E Kaiser, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 108 Whitehall Rd, Albany, NY 12209 Phone: 518-462-7258 Fax: 518-462-7265 | |
Dr. Jessica Sofranko Kisenwether, PHD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 432 Western Ave, Albany, NY 12203 Phone: 518-337-4777 Fax: 518-337-2313 | |
Ms. Taryn Lesvia Penebaker, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 26 Computer Dr E, Albany, NY 12205 Phone: 518-438-4800 | |
Joanne Coffey, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 314 S Manning Blvd, Albany, NY 12208 Phone: 518-437-5717 | |
Miss Cristina Lynn Silva, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 43 New Scotland Ave, Communication Disorders Department Mc 128, Albany, NY 12208 Phone: 518-262-4526 | |
Anthony Richard Amitrano, MSCCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 50 Philip St, Albany, NY 12207 Phone: 518-671-3777 |